Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58,874,321
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
38,482,247
-
Shares change
-
+3,318,933
-
Total reported value, excl. options
-
$622,313,434
-
Value change
-
+$52,888,872
-
Put/Call ratio
-
19.83%
-
Number of buys
-
60
-
Number of sells
-
-60
-
Price
-
$16.18
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2014
151 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2014.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,482,247 shares
of 58,874,321 outstanding shares and own 65.36% of the company stock.
Largest 10 shareholders include FMR LLC (4,569,496 shares), BAKER BROS. ADVISORS LP (4,372,153 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,426,791 shares), Palo Alto Investors, LLC (3,240,424 shares), PAULSON & CO INC (3,200,000 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,740,400 shares), Signpost Capital Advisors, LP (1,688,952 shares), State Street Corp (1,551,918 shares), Invesco Ltd. (1,353,054 shares), and BlackRock Fund Advisors (1,244,343 shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.